Not investment advice. Data and computed figures, for information only.

J B Chemicals & Pharmaceuticals Ltd

NSE: JBCHEPHARM

₹2,408.90

−₹97.10 (−3.87%)

NSE · 16 Jul 2026, close

NSE

Market Cap

₹34,799 Cr

CMP

₹2,408.90

52-wk High / Low

₹2,526 / 1,639

P/E

47.7

P/B

8.4

Book Value

₹259.0

Div Yield

1.02%

ROCE

26.0%

ROE

19.2%

Face Value

₹1

D/E

0.00

Not enough history yet

We have 0 fiscal years and 23 quarters of filings. Most of these scores need at least two full fiscal years to mean anything.

Graham NumberAvailable

Margin changeAvailable

Holder deltasAvailable

Piotroski F-ScoreNext fiscal year

ROE stability, sustainable growth5 fiscal years

	Name	P/E	Mar Cap ₹ Cr	ROCE %	ROE %

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	3,149	896	882	845	3,484	1,004	1,001	963	3,918	1,094	1,085	1,065	4,148
Expenses	2,454	664	638	621	2,587	724	730	709	2,886	793	775	769	3,040
Operating Profit	696	232	244	223	897	280	271	255	1,032	301	310	296	1,107
OPM %	22.1%	25.9%	27.7%	26.4%	25.7%	27.9%	27.1%	26.5%	26.3%	27.5%	28.6%	27.8%	26.7%
Other Income	10	6	8	7	37	6	10	8	38	15	15	18	33
Interest	36	12	10	12	44	6	2	3	12	1	1	2	6
Depreciation	114	31	32	34	138	41	42	42	171	43	44	45	182
Profit before tax	555	194	209	184	752	240	237	218	887	272	279	267	952
Net Profit	410	142	151	134	553	177	175	162	660	202	208	198	709
EPS (₹)	26.48	9.19	9.72	8.61	35.61	11.39	11.24	10.45	42.37	12.97	13.27	12.63	44.19

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	−14	127	140	201	123	194	276	315	170	626	801	902	704
Cash from Investing Activity	−142	−112	−26	−45	−21	−28	24	−231	2	−962	−404	−296	−586
Cash from Financing Activity	12	−1	−100	−184	−60	−156	−306	−87	−138	357	−385	−580	−123
Net Cash Flow	−144	13	15	−28	43	11	−6	−3	34	20	11	27	−5

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROCE %	13.0	13.0	15.0	14.0	11.0	18.0	23.0	33.0	23.0	22.0	25.0	26.0	26.0
ROE %	—	—	—	—	—	—	—	—	—	—	—	—	19.2
EPS (₹)	3.63	5.92	9.58	10.85	8.28	12.05	17.60	28.98	24.93	26.48	35.61	42.37	44.19
Book Value (₹)	—	—	—	—	—	—	—	—	—	—	—	—	259.0
Face Value (₹)	—	—	—	—	—	—	—	—	—	—	—	—	1
P/E	—	—	—	—	—	—	—	—	—	—	—	—	47.7
Div Yield %	—	—	—	—	—	—	—	—	—	—	—	—	1.02
NPM %	6.1	8.7	13.5	13.7	9.9	11.8	15.3	22.0	15.9	13.0	15.9	16.8	17.1
OPM %	14.0	16.0	17.0	17.0	15.0	19.0	21.0	27.0	22.0	22.0	26.0	26.0	27.0
D/E	0.09	0.13	0.16	0.04	0.02	0.02	0.02	0.02	0.03	0.23	0.13	0.01	0.00
P/B	—	—	—	—	—	—	—	—	—	—	—	—	8.4

Compounded sales growth

10 years+13.0%

5 years+15.0%

3 years+10.0%

TTM+6.0%

Compounded profit growth

10 years+18.0%

5 years+13.0%

3 years+22.0%

TTM+14.0%

Stock price CAGR

10 years+33.0%

5 years+24.0%

3 years+27.0%

Last year+29.0%

Return on equity

10 years18.0%

5 years19.0%

3 years20.0%

Last year19.0%

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	55.76%	55.84%	56.02%	55.91%	55.91%	54.00%	53.93%	53.78%	47.84%	48.80%
FIIs	5.46%	5.32%	5.34%	7.18%	7.54%	9.22%	8.62%	11.06%	18.30%	16.33%
DIIs	9.46%	12.75%	15.82%	14.56%	13.17%	16.89%	19.08%	18.38%	18.71%	21.38%
Government	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%
Public	29.32%	26.10%	22.82%	22.35%	23.38%	19.89%	18.35%	16.78%	15.13%	13.48%
No. of shareholders	32,069	34,095	32,429	35,211	65,718	61,314	56,633	63,892	63,948	74,043

Change since Jun 2023 (pp)

Promoters −6.96FIIs +10.87DIIs +11.92Public −15.84

Announcements

Letter To Shareholders - Integrated Annual Report 2025-2627 May - 50th AGM on June 17, 2026; Integrated Annual Report FY 2025-26 dispatched.Announcement under Regulation 30 (LODR)-Newspaper Publication Business Responsibility and Sustainability Reporting (BRSR)25 May - Submitted FY 2025-26 BRSR with ESG disclosures and reasonable assurance.Reg. 34 (1) Annual Report.Intimation Of Notice Of AGM To Be Held On June 17, 202625 May - 50th AGM on June 17, 2026; record date May 29, final dividend Rs 9.30, interim Rs 12.70.

Annual reports

Financial Year 2026from bse Financial Year 2025from bse Financial Year 2024from bse Financial Year 2023from bse Financial Year 2022from bse

Credit ratings

Rating update Rating update Rating update Rating update Rating update

Concalls

May 2026Transcript May 2026Recording Jan 2026Transcript Jan 2026PPT Jan 2026Recording Nov 2025Transcript Nov 2025PPT Aug 2025Transcript Aug 2025PPT Jun 2025PPT

29 May 2026DIVIDENDDividend - Rs 9.30 Per Share—

11 Feb 2026DIVIDENDInterim Dividend - Rs 12.70 Per Share—

30 Jul 2025DIVIDENDDividend - Rs 7 Per Share—

7 Feb 2025DIVIDENDInterim Dividend - Rs 8.50 Per Share—

14 Aug 2024DIVIDENDDividend - Rs 6.75 Per Share—

16 Feb 2024DIVIDENDInterim Dividend - Rs 5.50 Per Share—

18 Sep 2023SPLITFace Value Split (Sub-Division) - From Rs 2/- Per Share To Re 1/- Per Share2 : 1

17 Aug 2023DIVIDENDDividend - Rs 9.25 Per Share—

17 Feb 2023DIVIDENDInterim Dividend - Rs 8.50 Per Share—

12 Aug 2022DIVIDENDDividend - Rs 8 Per Sh—

23 Feb 2022DIVIDENDInterim Dividend - Rs 8.50 Per Share—

1 Sep 2021DIVIDEND Annual General Meeting/Dividend - Rs 8 Per Share—

18 Feb 2021DIVIDEND Interim Dividend - Rs. 8.50 Per Share—

22 Sep 2020DIVIDEND Annual General Meeting/Dividend - Re 1 Per Share—

3 Mar 2020DIVIDEND Interim Dividend - Rs 10 Per Share—

14 Aug 2019DIVIDEND Dividend - Rs 5 Per Share—

27 Aug 2018DIVIDEND Dividend Rs 2/- Per Share—

11 Sep 2017DIVIDEND Annual General Meeting/Dividend - Re 1/- Per Share—

11 Aug 2016DIVIDEND Dividend - Re 0.50/- Per Share—

17 Mar 2016DIVIDEND Interim Dividend -Rs 4.50/- Per Share (Purpose Revised)—

6 Aug 2015DIVIDENDAnnual General Meeting/Final Dividend Rs.4/- Per Share And Special Dividend Rs.10/- Per Share—

J B Chemicals & Pharmaceuticals Ltd

Price+49.2% over 1Y

āagman read

Peer comparison

Quarterly results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Growth

Shareholding pattern

Documents

Corporate actions